Yankees Suddenly Face A Bigger Max Fried Concern Than October

As the Yankees ponder their next move, the recovery of Max Fried from elbow surgery casts a significant shadow over their 2027 championship dreams.

Buried in the aftermath of the Yankees’ October collapse was a detail that could matter a whole lot more in 2027 than it did in the moment: Max Fried had surgery to remove bone chips from his left elbow.

That news barely registered while New York was still untangling another postseason mess. It should have.

Fried was the last starter the Yankees trusted in Game 3 of the Division Series, and it was his outing against the Rays that closed the book on their season. He lasted 5 2/3 innings, gave up four earned runs and took the loss in Tampa Bay’s 4-3 sweep-clinching win.

The Yankees never publicly flagged any health issue at the time. But Fried’s performance fit a season that never quite matched the standard he set in 2025, when he won 19 games. In 2026, he was solid more often than dominant, and that was enough to leave the Yankees exposed when they needed him most.

The elbow story, though, stretches beyond one surgery. Fried dealt with elbow trouble all summer and went on the injured list twice.

Both times, the diagnosis was a bone bruise. According to Dr.

Spencer Stein, an orthopedic sports medicine surgeon at NYU Langone Health, that kind of issue can lead to the bone chips Fried eventually had removed.

“From the pitching motion, the back of the elbow bones pinch against each other,” said Dr. Spencer Stein, orthopedic sports medicine surgeon at NYU Langone Health. “With bone bruises, you can get extra bone formation, and that extra bone formation can break off and get some loose pieces in there.”

Stein, who did not examine Fried, also said bone chips can come back. That leaves a real question hanging over Fried as he heads into his 11th big league season in 2027. There’s also the matter of his Tommy John surgery, which he had in 2014 while in the Padres’ system.

Even a repaired ligament can eventually run into valgus extension overload syndrome, where the ligament gradually loosens. That can, in turn, set the stage for a bone bruise.

The Yankees knew they were taking on injury risk when they gave Fried an eight-year, $218 million deal before the 2025 season. He delivered when Gerrit Cole was out following elbow reconstruction surgery, and Fried’s 19 wins were a career best. He also threw 195 innings, another personal high, and that workload raises its own obvious question: did it help trigger the bone bruises, the bone chips and the surgery?

That question matters because the Yankees are looking at 2027 as a year when their best path back to a title runs through their rotation. They need Cam Schlittler, Cole and Fried to carry the load together.

Schlittler isn’t the concern after winning the American League Cy Young Award by unanimous vote. Cole, now sliding into the No. 2 spot in the rotation, also doesn’t appear to be facing an immediate issue.

Fried is the one who leaves the Yankees uneasy.

His Game 3 start against the Rays now looks even more complicated in hindsight. Aaron Boone passed over Carlos Rodon, who had not pitched in nearly two weeks after throwing eight shutout innings against Tampa Bay on Sept. 22, and went with Fried instead.

The move didn’t work. Fried allowed two home runs, including a two-run blast by Victor Mesa Jr. in the sixth inning that ended the Yankees’ season.

The numbers from Fried’s year were still strong on paper: a 2.80 ERA and a 0.99 WHIP. But the rest of the profile pointed the other way. He finished 5-5, his swing-and-miss percentage was 10.3 percent, the second-lowest of his career, hitters made contact 77.4 percent of the time, and his 49.1 percent ground-ball rate was the lowest he’d ever posted.

None of that guarantees Rodon would have changed the outcome. Scouts believed Tampa Bay was the better team in both the regular season and the playoffs, and the Yankees were outplayed from start to finish.

Still, the larger issue remains the same: if the Yankees are going to end a 17-year championship drought, they need Fried to be healthy and effective deep into the life of that contract. He’ll be entering his age-33 season with nearly 1,200 innings on his arm. The surgery was successful, the Yankees say, and Fried is expected to be ready for spring training.

But as the calendar turns toward 2027, the Yankees are left hoping the elbow stays quiet. In this case, that hope is doing a lot of heavy lifting.

In Other News...

Yankees May Finally Have What It Takes To Land Hunter Goodman

The Yankees had Hunter Goodman on their radar at the trade deadline, but Colorado never moved him then, even as New York kept looking for ways to add offense behind the plate. Goodmans bat has only made the fit more obvious since, after a strong 2026 season that included 41 home runs and a road total that stood out for a primary catcher.

This offseason, the Rockies sound more willing to listen as they try to patch a pitching staff that needs help in a big way, and that opens the door for a different kind of deal than the one New York explored in July. The Yankees have pitching assets they could put into a package, which gives them a path back into a conversation that was already active once and may finally have the pieces to move forward. [Read more 🡒]

Yankees Linked To A Blockbuster Idea Fans Will Strongly Debate

Jim Bowden floated a trade idea that would certainly get Yankees fans talking, one that would send All-Star infielder Otto Lopez from Miami to the Bronx in exchange for Anthony Volpe, Jasson Dominguez and Will Warren. The concept is straightforward enough on paper: New York would be trying to shore up its middle infield and add another bat to the lineup, while Miami would be getting a package built around younger, controllable talent.

For the Yankees, the appeal is obvious, but so is the price. Volpe remains a central figure in the organizations infield plans, Dominguez still carries major upside, and Warren gives the Marlins another arm to consider. It is all purely hypothetical for now, though, and there has been no indication from either club that anything close to this kind of blockbuster is actually in motion. [Read more 🡒]

Yankees Just Got A New Trade Deadline Edge They Could Use Soon

Dustin Mays new three-year, $52.5 million deal with the White Sox is the kind of move that can ripple beyond one clubhouse. For the Yankees, it offers a fresh reference point as they weigh how other teams might value controllable arms, especially pitchers like Will Warren and Ryan Weathers, whose appeal comes from a mix of team control, upside and the kind of durability questions front offices always have to sort through.

For New York, that matters because the trade deadline is rarely just about what the Yankees need, but what the market will pay for what they can spare. If pitching prices keep climbing, the Yankees could find themselves with a better lane to deal from, whether they are chasing help on the mound or looking to add an infielder. The challenge now is figuring out which clubs are willing to meet that price and which direction New York wants to push when the offers start coming in. [Read more 🡒]